tirzepatide 13 units Letter of Medical Necessity Tirzepatide Injections Chicago | XSculpt

| Last Updated: January 30th, 2024 Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist (RA) that is manufactured by Eli Lilly and Company

Per a March 3, 2026 FDA press announcement (FDA.gov press announcement, March 3, 2026), the FDA issued warning letters to 30 telehealth companies for making false or misleading claims about compounded GLP-1 products, including claims that implied sameness with FDA-approved medications

Common compounded formulations include: Tirzepatide with cyanocobalamin (B12) : Pink to red Tirzepatide with glycine and B12 : Pink to red (glycine does not affect color) Tirzepatide with methylcobalamin : Pink to red (similar shade to cyanocobalamin) Tirzepatide with niacinamide : Clear to very faint yellow (no B12 means no pink) Visual comparison table Notice that one factor remains constant across every formulation in that table: clarity

No, Tirzepatide is not the same as Trulicity (dulaglutide)